APA (7th ed.) Citation

C, B., T, T., J, L., EP, H., ES, K., RJ, D., . . . PJ, N. (2021). Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M1 receptor agonist, in healthy younger adult and elderly subjects: A multiple ascending dose study. Alzheimer's research & therapy, 13(1), 87. https://doi.org/10.1186/s13195-021-00816-5

Chicago Style (17th ed.) Citation

C, Bakker, et al. "Safety, Pharmacokinetics and Exploratory Pro-cognitive Effects of HTL0018318, a Selective M1 Receptor Agonist, in Healthy Younger Adult and Elderly Subjects: A Multiple Ascending Dose Study." Alzheimer's Research & Therapy 13, no. 1 (2021): 87. https://doi.org/10.1186/s13195-021-00816-5.

MLA (9th ed.) Citation

C, Bakker, et al. "Safety, Pharmacokinetics and Exploratory Pro-cognitive Effects of HTL0018318, a Selective M1 Receptor Agonist, in Healthy Younger Adult and Elderly Subjects: A Multiple Ascending Dose Study." Alzheimer's Research & Therapy, vol. 13, no. 1, 2021, p. 87, https://doi.org/10.1186/s13195-021-00816-5.